infectious disease Flashcards
clean surgical wound
no break techiniqueno inflammationclean areas: cardiac, vascular, neuro, ortho, ophtha
clean contaminated wound
POTENTIALLY colonized hollow viscus disrupted (head, neck, oral, abd, gym surg)minor break in procedure
contaminated wound
** penetrating trauma lt 4 hours old **inflammation already, MAJOR break in technique, major hollow organ spill
dirty wound
frank purulent drainage, abscess ** penetrating trauma gt 4 hours old **
clean areas of wounds
cardiac, vascular, neuro, ortho, ophtha
MRSA + central line relationship
87% bacteremic pts18-55% endocarditis ptshad central line
common MRSA sites
wounds, nares, trachea, perinum
MRSA - how resistance works
produce beta lactamasealtered penicillin-binding proteins (PBP) - rx efficacy needs high affinity between drug & PBP
- MRSA: at risk pops
aged / debilitatedmales/p surgery + lengthy hospymultiple invasive proceduresICU, trauma, burnindwelling cath, intravasc device, ET tube, ventprev hospyprior prolonged abx txpresence/size of wound
MRSA resistant to these meds
methicillinaminoglycosides: gentamicinerythromycintetracyclinescephalosporinsquinolones: cipro, floxin
what counts as epidemic
greater than 4 cases over baseline per month
MRSA + surgical pt care approach highlights
- tx remote infection prior to surgery (urine C&S + nasal swabs)- good control of glucose levels (150 ok, higher = increased infx risk)- special bathing protocol (air dry + chlorhexidine)- universal precautions always
MRSA + infected/colonized pt care highlights
CONTACT ISOLATION- gloves + hand wash most important- colonized + asymp + no surgical + no pna risk = NO NEED TO TREAT
MRSA: don’t need to treat who
pts who are… colonized + symp + no surgery + no pna risk
** MRSA TREATMENT ** x4
vanc (IV) 15 - 20 mg/kg/dose Q8-12 hrs- bacteremia - vanc or dapto 2 wk- infective endocarditis: vanc 6 wk- CAP (one of the following)– vanc IV 7-21 – linezolid (zyvox) PO/IV – clindamycin IV
vanc-resistant enterococcus
4th leading cause HAI in ICUintrinsic & acquired resistance possiblepoor prognosis w high mort rate
VRE key risk factors
- broad spectrum cephalosporins- parenteral vancomycin
** VRE TX OPTIONS **
newer abx: zyvoxcombo tx: pcn + vanc + gent
vanc resis r/t heavy use 3rd gen cephalosporins
klebsiella pneumoniae
** skin infection tx **
ORAL- clindamycin- bactrim (sulfa-tmp)- tetracycline- linezolid (zyvox)
** cellulitis organisms ** common / less (x3 each)
BOOYEAH: gram pos cocci- beta hemolytic strep (A, B, C, G, F)- staph aureus- MRSAEHHH?- gram neggies- h flu- non-spore forming anaerobes
cellulitis at risk pops
diabeteselderlypedal edemavenous or lymphatic compromiseobese: abdominal wall cellulitis
cellulitis s/s** + intensification + toxic
** erythema w irregular borders but “spreading” **tenderness, warmth, pain, edemalymphadenopathyno vesicles or bullaeINTENSIFY RAPIDLY (edema, eryth spread 6-36 hours)TOXIC: tachy(cardic/pneic), hypotensive, septicemia
spread of cellulitis s/s
INTENSIFY RAPIDLYeryth + ede 6 - 36 hours spread
important ddx for cellulitis
VTE nec fasc (appears toxic - HAS BULLAE and cellulitis don’t)
nec fasc s/s
skin necrosisbullaecrepitusanesthesia over skinrhabdomyolysisTOXIC!